Calea: Parenteral Nutrition

Department of Health and Social Care written question – answered on 10th March 2020.

Alert me about debates like this

Photo of Thangam Debbonaire Thangam Debbonaire Opposition Whip (Commons)

To ask the Secretary of State for Health and Social Care, what criteria his Department used to approve Calea UK Ltd as the supplier of total parenteral nutrition to the NHS.

Photo of Jo Churchill Jo Churchill The Parliamentary Under-Secretary for Health and Social Care

The criteria used to approve manufacturers is set out in the “guide to good manufacturing practices” and is monitored via inspection processes performed by the Medicines Healthcare Regulatory Authority (MHRA). If a company has met these standards, an “authorize to manufacture” is granted. If upon routine re-inspections, the manufacturing processes do not meet the acceptable standard, further actions are taken, as with the case of Calea UK Ltd.

NHS England and NHS Improvement’s Commercial Medicines Unit (CMU) is responsible for awarding framework agreements for England, in line with procurement regulations, for parenteral nutrition. All suppliers including Calea UK Ltd are required to provide available production capacity, satisfy quality, safety, finance and governance requirements and evidence that they hold a licence with the MHRA and meet its regulatory requirements.

Does this answer the above question?

Yes2 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.